Kevin S. Murnane,Ajay K. Banga,Sindhu S. Ganti,Ying Jiang,Ashana Puri
申请号：
US16346180
公开号：
US20190298661A1
申请日:
2017.10.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Transdermal patches and transdermally applyable pharmaceutical compositions containing an effective amount of at least one drug are disclosed. The at least one drug may be: (a) phenmetrazine； (b) 4-benzylpiperidine； (c) 3-flouroamphetamine； (d) a DA/NE releaser compound having formula (I): wherein each of R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 is independently hydrogen, a halogen, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted alkoxy group, and when one or more substituents is present on an alkyl group, an alkoxy group, or both, each substituent is independently a halogen； or (e) any combination thereof. Methods of making transdermal patches and transdermally applyable pharmaceutical compositions and methods of using transdermal patches and transdermally applyable pharmaceutical compositions are also disclosed.
